AU8769791A - Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence - Google Patents

Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence

Info

Publication number: AU8769791A
Authority: AU; Australia
Prior art keywords: integrinaffinity; sequence; active; proteins; protein
Prior art date: 1990-10-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU87697/91A

Inventor

Keith Martyn Dawson

Richard Mark Edwards

Anthony Fallon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Vernalis R&D Ltd

Original Assignee

British Bio Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-24

Filing date

1991-10-23

Publication date

1992-05-26

1991-10-23 Application filed by British Bio Technology Ltd filed Critical British Bio Technology Ltd

1992-05-26 Publication of AU8769791A publication Critical patent/AU8769791A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU87697/91A 1990-10-24 1991-10-23 Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence Abandoned AU8769791A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9023149		1990-10-24
GB909023149A GB9023149D0 (en)	1990-10-24	1990-10-24	Proteins and nucleic acids

Publications (1)

Publication Number	Publication Date
AU8769791A true AU8769791A (en)	1992-05-26

Family

ID=10684292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU87697/91A Abandoned AU8769791A (en)	1990-10-24	1991-10-23	Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence

Country Status (7)

Country	Link
AU (1)	AU8769791A (en)
GB (1)	GB9023149D0 (en)
IE (1)	IE913675A1 (en)
NZ (1)	NZ240307A (en)
PT (1)	PT99293A (en)
WO (1)	WO1992007874A1 (en)
ZA (1)	ZA918423B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0702696B1 (en) *	1993-06-11	2003-07-30	Merrell Pharmaceuticals Inc.	Trifunctional antithrombin and antiplatelet peptides
US5708160A (en) *	1995-04-26	1998-01-13	The National Research Council	HSP-60 genomic locus and primers for species identification
GB9705787D0 (en)	1997-03-20	1997-05-07	Thrombosis Res Inst	Modified dendroaspins
WO2009040028A2 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
US10533044B2 (en)	2014-01-06	2020-01-14	The General Hospital Corporation	Integrin Antagonists
CN113201049B (en) *	2015-08-05	2022-10-04	陕西麦科奥特科技有限公司	Multi-target compound with anticoagulant and antiplatelet activity, preparation method and application
CN113402583B (en) *	2021-06-19	2023-03-21	江西农业大学	QGK tripeptide and application thereof
CN113933377B (en) *	2021-09-28	2024-08-13	深圳湾实验室	Compound and mass spectrum standard and calibration product thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8516421D0 (en) *	1985-06-28	1985-07-31	Biotechnology Interface Ltd	Fibronectins
GB8628398D0 (en) *	1986-11-27	1986-12-31	Central Blood Lab Authority	Pharmaceutically-active conjugates
EP0311589B1 (en) *	1987-10-09	1994-03-23	Monsanto Company	Modified tissue plasminogen activator
EP0333356A3 (en) *	1988-03-04	1990-12-19	Biogen, Inc.	Hirudin peptides
FR2628429B1 (en) *	1988-03-08	1990-12-28	Transgene Sa	HIRUDINE VARIANTS, USES THEREOF AND PROCESSES FOR OBTAINING THEM
DE3831714A1 (en) *	1988-09-17	1990-03-22	Basf Ag	TPA-SIMILAR POLYPEPTIDES, THEIR PREPARATION AND USE
JP2878341B2 (en) *	1989-03-03	1999-04-05	学校法人藤田学園	Artificial functional polypeptide

1990
- 1990-10-24 GB GB909023149A patent/GB9023149D0/en active Pending
1991
- 1991-10-18 IE IE367591A patent/IE913675A1/en not_active Application Discontinuation
- 1991-10-22 ZA ZA918423A patent/ZA918423B/en unknown
- 1991-10-22 PT PT99293A patent/PT99293A/en not_active Application Discontinuation
- 1991-10-23 WO PCT/GB1991/001860 patent/WO1992007874A1/en active Application Filing
- 1991-10-23 NZ NZ240307A patent/NZ240307A/en unknown
- 1991-10-23 AU AU87697/91A patent/AU8769791A/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA918423B (en)	1993-04-22
GB9023149D0 (en)	1990-12-05
WO1992007874A1 (en)	1992-05-14
PT99293A (en)	1992-09-30
IE913675A1 (en)	1992-05-22
NZ240307A (en)	1993-03-26

Publication	Publication Date	Title
AU3228789A (en)	1989-10-05	Biologically active proteins
AU645342B2 (en)	1994-01-13	Antimicrobial peptides and an antimicrobial agent
DE69526801D1 (en)	2002-06-27	AEROSOL FORMULATIONS WITH PEPTIDES AND PROTEINS
AU7865591A (en)	1991-11-27	Method and means for extending the host range of insecticidal proteins
EP0410323A3 (en)	1992-04-08	Immobilization of proteins and peptides on insoluble supports
AU4648697A (en)	1998-04-14	Methods and devices for preparing protein concentrates
AU3321595A (en)	1996-03-04	Recombinant production of biologically active peptides and proteins
AU5102990A (en)	1990-05-01	Fungicidally active preparations
AU6428890A (en)	1991-04-18	Therapeutic peptides and proteins
AU2036495A (en)	1996-01-11	Crucifer AFT proteins and uses thereof
AU7400091A (en)	1991-10-10	Inhibitors of the advanced glycosylation of proteins and methods of use therefor
AU633294B2 (en)	1993-01-28	Motilin-like polypeptide and use thereof
AU1382488A (en)	1988-09-29	Cyclic peptides and their preparation
EP0129582A4 (en)	1987-09-02	Orally administered biologically active peptides and proteins.
AU8072691A (en)	1992-01-23	Pharmaceutical preparations
AU8769791A (en)	1992-05-26	Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence
AU1435695A (en)	1995-07-10	Recombinant human thymopoietin proteins and uses therefor
AU7238098A (en)	1998-12-08	Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants
AU1180088A (en)	1988-08-24	Protein extracts
AU610900B2 (en)	1991-05-30	Immunosuppressant peptides
AU3890689A (en)	1990-02-01	Human protein c mutants and method for preparing the same
AU3193089A (en)	1989-09-06	Prepromotilin and motilin-associated peptide (map)
AU2117388A (en)	1989-04-27	Recombinant htlv-iii proteins and uses thereof
AU6301698A (en)	1998-09-09	Anti-hiv peptides and proteins
AU4588189A (en)	1990-06-21	Imidazole-containing peptide and preparation thereof